Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Defining remission in childhood-onset lupus : PReS-endorsed consensus definitions by an international task force
Authors:ID Smith, Eve Mary Dorothy (Author)
ID Aggarwal, Amita (Author)
ID Ainsworth, Jenny (Author)
ID Al-Abadi, Eslam (Author)
ID Avčin, Tadej (Author)
ID Bortey, Lynette (Author)
ID Burnham, Jon (Author)
ID Ciurtin, Coziana (Author)
ID Hedrich, Christian M. (Author)
ID Kamphuis, Sylvia (Author), et al.
Files:.pdf PDF - Presentation file, download (767,89 KB)
MD5: 123E1FD34CC7DDAA26DDA6C4B78AE164
 
URL URL - Source URL, visit https://www.sciencedirect.com/science/article/pii/S1521661624001050
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Objective: To derive childhood-onset SLE (cSLE) specific remission definitions for future treat-to-target (T2T) trials, observational studies, and clinical practice. Method:s The cSLE International T2T Task Force conducted Delphi surveys exploring paediatric perspectives on adult-onset SLE remission targets. A modified nominal group technique was used to discuss, refine, and agree on the cSLE remission target criteria. Results: The Task Force proposed two definitions of remission: ‘cSLE clinical remission on steroids (cCR)’ and ‘cSLE clinical remission off steroids (cCR-0)’. The common criteria are: (1) Clinical-SLEDAI-2 K = 0; (2) PGA score < 0.5 (0–3 scale); (4) stable antimalarials, immunosuppressive, and biologic therapy (changes due to side-effects, adherence, weight, or when building up to target dose allowed). Criterion (3) in cCR is the prednisolone dose ≤0.1 mg/kg/day (maximum 5 mg/day), whereas in cCR-0 it is zero. Conclusions: cSLE definitions of remission have been proposed, maintaining sufficient alignment with the adult-SLE definition to facilitate life-course research.
Keywords:autoinflammatory diseases, lupus, treat-to-target, remission, children
Publication status:Published
Publication version:Version of Record
Year of publishing:2024
Number of pages:str. 1-9
Numbering:Vol 263
PID:20.500.12556/DiRROS-29776 New window
UDC:616-097
ISSN on article:1521-6616
DOI:10.1016/j.clim.2024.110214 New window
COBISS.SI-ID:205657859 New window
Note:
Publication date in DiRROS:05.06.2026
Views:51
Downloads:30
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Clinical immunology
Shortened title:Clin Immunol
Publisher:Academic Press
ISSN:1521-6616
COBISS.SI-ID:1941268 New window

Document is financed by a project

Funder:WT - Wellcome Trust
Project number:204822
Name:Institutional Strategic Support Fund

Funder:Other - Other funder or multiple funders
Funding programme:Versus Arthritis
Project number:20621
Name:Arthritis Research UK National Experimental Arthritis Treatment Centre for Children
Acronym:ARUK

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back